CN Patent

CN102512379A — 一种新型棘白菌素类抗真菌药物组合物及其制备方法

Assigned to Shenzhen Jianxiang Biological Pharmaceutical Co Ltd · Expires 2012-06-27 · 14y expired

What this patent protects

本发明属于药用制剂技术领域，提供一种米卡芬净为有效成分的注射制剂组合物。这种注射制剂组合物，包括米卡芬净或其药学上可用的盐5-200mg/ml、赋形剂5-250mg/ml、缓冲液10-250mM及适量氢氧化钠或盐酸调节pH值为4.0-7.0。

USPTO Abstract

本发明属于药用制剂技术领域，提供一种米卡芬净为有效成分的注射制剂组合物。这种注射制剂组合物，包括米卡芬净或其药学上可用的盐5-200mg/ml、赋形剂5-250mg/ml、缓冲液10-250mM及适量氢氧化钠或盐酸调节pH值为4.0-7.0。

Drugs covered by this patent

Patent Metadata

Patent number
CN102512379A
Jurisdiction
CN
Classification
—
Expires
2012-06-27
Drug substance claim
No
Drug product claim
No
Assignee
Shenzhen Jianxiang Biological Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.